U.S. Blames Drug Shortages on Low Prices and a ‘Broken Marketplace’

A government task force suggested that providers pay more for lifesaving generics and that the drugs receive quality ratings.

from NYT > Health https://ift.tt/2Jz45Jf
via health&fitness